Values of serum intestinal fatty acid-binding protein, fecal calprotectin, and fecal human β-defensin 2 for predicting necrotizing enterocolitis
Authors:
Open Access
- 16 March 2024
- journal article
- research article
- Published by Springer Nature in BMC Pediatrics
- Vol. 24 (1) , 1-8
Abstract
Background: This study aimed to assess the diagnostic potential of serum intestinal fatty acid-binding protein (I-FABP), fecal calprotectin (FC), and fecal human β-defensin 2 (hBD2) in predicting necrotizing enterocolitis (NEC) in preterm infants. Methods: A prospective cohort of neonates with a gestational age < 32 weeks, suspected of NEC, was enrolled between June 2021 and December 2022. Serum I-FABP, FC, and fecal hBD2 levels were measured upon NEC suspicion, and diagnosis was confirmed through radiological examination or surgical intervention. Diagnostic precision of serum I-FABP, FC, and fecal hBD2 was assessed using a logistic regression model with multiple variables. Results: The study included 70 neonates (45 males, 25 females), with 30 developing NEC (40% Stage III, n = 12; 60% Stage II, n = 18) and 40 in the control group. NEC patients exhibited significantly higher serum I-FABP and FC levels (4.76 ng/mL and 521.56 µg/g feces, respectively) than those with other diagnoses (1.38 ng/mL and 213.34 µg/g feces, respectively; p ˂ 0.05 for both biomarkers). Stage II NEC neonates showed elevated fecal hBD2 levels (376.44 ng/g feces) than Stage III NEC neonates and controls (336.87 ng/g and 339.86 ng/g feces, respectively; p ˂ 0.05). No such increase was observed in infants progressing to Stage III NEC. Using a serum I-FABP threshold of > 2.54 ng/mL yielded 76.7% sensitivity, 87.5% specificity, 82.1% positive predictive value (PPV), and 83.3% negative predictive value (NPV). For FC (cutoff > 428.99 µg/g feces), corresponding values were 76.7% sensitivity, 67.5% specificity, 63.9% PPV, and 79.4% NPV. Conclusion: Serum I-FABP and FC levels are valuable for early NEC detection and provide insights into disease severity. Low fecal hBD2 levels suggest an inadequate response to luminal bacteria, potentially rendering these infants more susceptible to NEC development or exacerbation.Keywords
Funding Information
- Fujian Provincial Health Technology Project (No.2020QNA026, No.2020QNA026, No.2020QNA026, No.2020QNA026, No.2020QNA026, No.2020QNA026)
- the Social Developmental Induction Program of Fujian Province (No.2019Y0058, No.2019Y0058, No.2019Y0058, No.2019Y0058, No.2019Y0058, No.2019Y0058)
- The Key Project of Natural Science Foundation of Fujian Province (No.2022J02049, No.2022J02049, No.2022J02049, No.2022J02049, No.2022J02049, No.2022J02049)
This publication has 39 references indexed in Scilit:
- Necrotizing Enterocolitis: Updates on Morbidity and Mortality OutcomesThe Journal of Pediatrics, 2020
- Differentiation of food protein-induced enterocolitis syndrome and necrotizing enterocolitis in neonates by abdominal sonographyJornal de Pediatria, 2020
- The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal DiseasesDigestive Diseases and Sciences, 2019
- Does Surgical Management Alter Outcome in Necrotizing Enterocolitis?Clinics in Perinatology, 2019
- Biomarker Discovery and Utility in Necrotizing EnterocolitisClinics in Perinatology, 2019
- Serial fecal calprotectin in the prediction of necrotizing enterocolitis in preterm neonatesJournal of Pediatric Surgery, 2019
- Point-of-Care Fecal Calprotectin Monitoring in Preterm Infants at Risk for Necrotizing EnterocolitisThe Journal of Pediatrics, 2018
- Fecal Calprotectin2018
- Clinical significance of FABP2 expression in newborns with necrotizing enterocolitisWorld Journal of Pediatrics, 2015
- Intestinal fatty acid-binding protein levels in Necrotizing Enterocolitis correlate with extent of necrotic bowel: results from a multicenter studyJournal of Pediatric Surgery, 2015